The Drug Enforcement Agency has announced that the House and Senate have reached a compromise that will make it tougher to get K2, "Spice" and other forms of synthetic marijuana.
Twenty-six drugs, most of them used in creating synthetic pot, have been added to Schedule I, meaning they have been found to have a high tendency towards being abused and have no medical use in the U.S.
"In addition to explicitly naming 26 substances, the legislation creates a new definition for 'cannabamimetic agents,' creating criteria by which similar chemical compounds are controlled," the DEA says.
The legislation also doubles the time to drugs will be placed on Schedule I, changing it from 18 months to 36.
"In recent years, a growing number of dangerous products have been introduced into the U.S. marketplace," the DEA says. "Products labeled as 'herbal incense' have become especially popular, especially among teens and young adults. These products consist of plant material laced with synthetic cannabinoids which, when smoked, mimic the delirious effects of THC, the psychoactive ingredient of marijuana."
The American Association of Poison Control Centers reported receiving almost 7,000 calls related to synthetic marijuana in 2011, as opposed to almost 3,000 in 2010.